Article Text

Download PDFPDF

Introduction/overview on clinical registries
Free
  1. D D Gladman1,
  2. A Menter2
  1. 1University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada
  2. 2Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA
  1. Correspondence to:
    Dr D Gladman
    Toronto Western Hospital, 399 Bathurst St ECW 5-034B, Toronto, Ontario, M5T 2S8, Canada; dafna.gladmanutoronto.ca

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Patient registries have become an important instrument in epidemiological studies in chronic disease. There are several types of registry (table 1). Administrative registries have been developed to identify patients with particular conditions, and these are then used in epidemiological studies to identify prevalence of certain conditions. For administrative registries, a limited amount of primarily demographic information is required as the purpose is only to identify patients rather than to learn as much as possible about an individual patient. Such registries exist in Europe, where patient information is recorded in common registries at each encounter with a physician or a healthcare facility.1–3 Such registries have been used to identify associations between the primary disease and other complications such as the development of cancer among patients with psoriasis.4

View this table:
Table 1

 Purpose of registries

Clinical registries have been developed specifically for drug trials. Some registries have been set up to identify patients who might be suitable for drug trials, whereas others have been developed for the management of the drug trial itself. Registries have also been set up as a surveillance mechanism to follow patients treated with particular medications.5 For the latter type of registry, more than simple demographic information, such as previous medications and level of disease activity, is gathered for individual patients.6

For a longitudinal observational cohort much more detailed information is required. Here …

View Full Text